Skip to Main Content

Regulatory Issues

ACR® is committed to representing and communicating radiologists’ perspectives to the executive branch of the U.S. government.

Federal regulatory and research agencies can have a profound impact on radiology practice and the future of medicine. ACR is committed to representing and communicating radiologists’ perspectives to policymakers, regulators and other agency staff throughout the executive branch of the U.S. government.

Information Blocking

The Information Blocking provision discourages interference by relevant providers, developers and networks of legally permissible access, exchange and use of electronic health information.

Artificial Intelligence and Digital Health

ACR advocates radiology’s perspective to the federal government with respect to artificial intelligence (AI) and digital health policy issues, including advocating for AI safety and effectiveness, technology innovation and data sharing.

AI Safety, Effectiveness and Quality Use

Advancing Technology Innovation

Data Sharing and Interoperability

Other Digital Health

Radiation Safety and Medical Use

ACR advocates radiology’s perspective to the federal government on medical radiation safety issues, such radiological materials licensing, authorized use, and drug/device oversight and availability to patients.

Radiological Materials Licensing and Medical Use

Nuclear Medicine Extravasation Reporting to Government

Federal Appropriations

ACR advocates for the highest possible funding levels for radiology and imaging related research to ensure medical progress and advancements in the field. Support for radiology research, including a wide range of diagnostics, treatments, and therapeutics are shared with congressional and government leaders, along with academic and research policies.

National Research Strategy

Funding for Radiology Research Innovation

Public Health and Population Screening

ACR advocates radiology’s perspective to the federal government concerning radiology related public health concerns, including population screening, guidelines and programs.

Cancer Screening

Patient Accessibility

For older public record documents from ACR to federal agencies please refer to regulations.gov, or contact Michael Peters, Senior Director, Government Affairs, or Katie Grady, Government Affairs Director.